We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Reagan-Udall Foundation Draws Congressional Criticism
FDA’s Reagan-Udall Foundation Draws Congressional Criticism
November 28, 2007
The chairwoman of the congressional subcommittee that funds the FDA objected to pharmaceutical industry funding for the Reagan-Udall Foundation, saying “undue influence by industry could harm the work of the FDA.”